Hikma Pharmaceuticals Plc using EPIC/TICKER code (LON:HIK) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘UNDERPERFORM’ today by analysts at Jefferies International. Hikma Pharmaceuticals Plc are listed in the Health Care sector within UK Main Market. Jefferies International have set their target price at 895 GBX on its stock. This would imply the analyst believes there is a potential downside of -10.6% from the opening price of 1001 GBX. Over the last 30 and 90 trading days the company share price has decreased 71 points and decreased 178 points respectively. The 1 year high share price is 2346 GBX while the 52 week low for the share price is 906.5 GBX.
Hikma Pharmaceuticals Plc has a 50 day moving average of 1,069.07 GBX and the 200 Day Moving Average price is recorded at 1,361.73. There are currently 240,625,806 shares in issue with the average daily volume traded being 652,183. Market capitalisation for LON:HIK is £2,390,376,816 GBP.